Hyperglycemia is associated with enhanced gluconeogenesis in a rat model of permanent cerebral ischemia

Molecular and Cellular Endocrinology

Volumn 367, Issue 1-2, 2013, Pages 50-56

  Wang, Ya Yu ^a,b,c   Chen, Chun Jung ^a   Lin, Shih Yi ^a,c   Chuang, Yu Han ^a   Sheu, Wayne Huey Herng ^a,c   Tung, Kwong Chung ^b  

^a TAICHUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^b NATIONAL CHUNG HSING UNIVERSITY   (Taiwan)

^c NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

Adipokines; AMPK; C EBP; Counter regulatory hormones; CREB; CRP; Gluconeogenesis; Inflammation; Insulin resistance; IR; IRS1; JNK; MCP 1; Stroke

Indexed keywords

CCAAT ENHANCER BINDING PROTEIN; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; GLUCAGON; GLUCOSE 6 PHOSPHATE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; INSULIN RECEPTOR; INSULIN RECEPTOR SUBSTRATE 1; MONOCYTE CHEMOTACTIC PROTEIN 1; PHOSPHOPYRUVATE CARBOXYLASE; RESISTIN; SYNAPTOPHYSIN; TRANSCRIPTION FACTOR FKHR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN ISCHEMIA; CONTROLLED STUDY; DISEASE ASSOCIATION; GENE EXPRESSION REGULATION; GLUCONEOGENESIS; GLUCOSE METABOLISM; HYPERGLYCEMIA; INSULIN RESISTANCE; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN PHOSPHORYLATION; QUANTITATIVE ANALYSIS; RAT; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; UPREGULATION;

ANIMALS; BLOOD GLUCOSE; BRAIN; BRAIN ISCHEMIA; DISEASE MODELS, ANIMAL; GENE EXPRESSION REGULATION; GLUCONEOGENESIS; HYPERGLYCEMIA; INSULIN; LIVER; MALE; RATS; RATS, SPRAGUE-DAWLEY; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTORS;

EID: 84873525601     PISSN: 03037207     EISSN: 18728057     Source Type: Journal    
DOI: 10.1016/j.mce.2012.12.016     Document Type: Article

References (37)

1. Aguirre V., Werner E.D., Giraud J., Lee Y.H., Shoelson S.E., White M.F. Phosphorylation of Ser307 in insulin receptor substrate-1 blocks interactions with insulin receptor and inhibits insulin action. J. Biol. Chem. 2002, 277:1531-1537.
2. Ahima R.S., Lazar M.A. Adipokines and the peripheral and neural control of energy balance. Mol. Endocrinol. 2008, 22:1023-1031.
3. Altarejos J.Y., Montminy M. CREB and the CRTC co-activators: sensors for hormonal and metabolic signals. Nat. Rev. Mol. Cell Biol. 2011, 12:141-151.
4. Brüning J.C., Gautam D., Burks D.J., Gillette J., Schubert M., Orban P.C., Klein R., Krone W., Müller-Wieland D., Kahn C.R. Role of brain insulin receptor in control of body weight and reproduction. Science 2000, 289:2122-2125.
5. Brunet A., Bonni A., Zigmond M.J., Lin M.Z., Juo P., Hu L.S., Anderson M.J., Arden K.C., Blenis J., Greenberg M.E. Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor. Cell 1999, 96:857-868.
6. Capes S.E., Hunt D., Malmberg K., Pathak P., Gerstein H.C. Stress hyperglycemia and prognosis of stroke in nondiabetic and diabetic patients: a systematic overview. Stroke 2001, 32:2426-2432.
7. Chen Z., Sheng L., Shen H., Zhao Y., Wang S., Brink R., Rui L. Hepatic TRAF2 regulates glucose metabolism through enhancing glucagon responses. Diabetes 2012, 61:566-573.
8. Dungan K.M., Braithwaite S.S., Preiser J.C. Stress hyperglycemia. Lancet 2009, 373:1798-1807.
9. Furnary A.P., Gao G., Grunkemeier G.L., Wu Y., Zerr K.J., Bookin S.O., Floten H.S., Starr A. Continuous insulin infusion in patients with diabetes mellitus undergoing coronary artery bypass grafting. J. Thorac. Cardiovasc. Surg. 2003, 125:1007-1021.
10. Grimble R.F. Inflammatory status and insulin resistance. Curr. Opin. Clin. Nutr. Metab. Care 2002, 5:551-559.
11. Guo S., Cichy S.B., He X., Yang Q., Ragland M., Ghosh A.K., Johnson P.F., Unterman T.G. Insulin suppresses transactivation by CAAT/enhancer-binding proteins beta (C/EBPbeta). Signaling to p300/CREB-binding protein by protein kinase B disrupts interaction with the major activation domain of C/EBPbeta. J. Biol. Chem. 2001, 276:8516-8523.
12. Harada S., Fujita-Hamabe W., Shichi K., Tokuyama S. The development of glucose intolerance after focal cerebral ischemia participates in subsequent neuronal damage. Brain Res. 2009, 1279:174-181.
13. Harada S., Fujita-Hamabe W., Tokuyama S. Effect of orexin-A on post-ischemic glucose intolerance and neuronal damage. J. Pharmacol. Sci. 2011, 115:155-163.
14. He L., Sabet A., Djedjos S., Miller R., Sun X., Hussain M.A., Radovick S., Wondisford F.E. Metformin and insulin suppresses hepatic gluconeogenesis through phosphorylation of CREB binding protein. Cell 2009, 137:635-646.
15. Hirosumi J., Tuncman G., Chang L., Görgün C.Z., Uysal K.T., Maeda K., Karin M., Hotamisligil G.S. A central role for JNK in obesity and insulin resistance. Nature 2002, 420:333-336.
16. Hotamisligil G.S. Inflammation and metabolic disorders. Nature 2006, 444:860-867.
17. Jitrapakdee S. Transcription factors and coactivators controlling nutrient and hormonal regulation of hepatic gluconeogenesis. Int. J. Biochem. Cell Biol. 2012, 44:33-45.
18. Kent T.A., Soukup V.M., Fabian R.H. Heterogeneity affecting outcome from acute stroke therapy: making reperfusion worse. Stroke 2001, 32:2318-2327.
19. Kim B., Sullivan K.A., Backus C., Feldman E.L. Cortical neurons develop insulin resistance and blunted Akt signaling: a potential mechanism contributing to enhanced ischemic injury in diabetes. Antioxid. Redox Signal. 2011, 14:1829-1839.
20. Malmberg K., Rydén L., Wedel H., Birkeland K., Bootsma A., Dickstein K., Efendic S., Fisher M., Hamsten A., Herlitz J., Hildebrandt P., MacLeod K., Laakso M., Torp-Pedersen C., Waldenström A. Intensive metabolic control by means of insulin in patients with diabetes mellitus and acute myocardial infarction (DIGAMI 2): effects on morbidity and mortality. Eur. Heart J. 2005, 26:650-661.
21. McCormick M.T., Muir K.W., Gray C.S., Walters M.R. Management of hyperglycemia in acute stroke. How, when, and for whom?. Stroke 2008, 39:2177-2185.
22. McCullough L.D., Zeng Z., Li H., Landree L.E., McFadden J., Ronnett G.V. Pharmacological inhibition of AMP-activated protein kinase provides neuroprotection in stroke. J. Biol. Chem. 2005, 280:20493-20502.
23. Minokoshi Y., Alquier T., Furukawa N., Kim Y.B., Lee A., Xue B., Mu J., Foufelle F., Ferré P., Birnbaum M.J., Stuck B.J., Kahn B.B. AMP-kinase regulates food intake by responding to hormonal and nutrient signals in the hypothalamus. Nature 2004, 428:569-574.
24. Niswender K.D., Morrison C.D., Clegg D.J., Olson R., Baskin D.G., Myers M.G., Seeley R.J., Schwartz M.W. Insulin activation of phosphatidylinositol 3-kinase in the hypothalamic arcuate nucleus: a key mediator of insulin-induced anorexia. Diabetes 2003, 52:227-231.
25. Obici S., Feng Z., Karkanias G., Baskin D.G., Rossetti L. Decreasing hypothalamic insulin receptors causes hyperphagia and insulin resistance in rats. Nat. Neurosci. 2002, 5:566-572.
26. Pandey A.K., Bhardwaj V., Datta M. Tumor necrosis factor-alpha attenuates insulin action on phosphoenolpyruvate carboxykinase gene expression and gluconeogenesis by altering the cellular localization of Foxa2 in HepG2 cells. FEBS J. 2009, 276:3757-3769.
27. Puigserver P., Rhee J., Donovan J., Walkey C.J., Yoon J.C., Orlente F., Kitamura Y., Altomonte J., Dong H., Accili D., Spiegelman B.M. Insulin-regulated hepatic gluconeogenesis through FOXO1-PGC-1 interaction. Nature 2003, 423:550-555.
28. Puigserver P., Rhee J., Lin J., Wu Z., Yoon J.C., Zhang C.Y., Krauss S., Mootha V.K., Lowell B.B., Spiegelman B.M. Cytokine stimulation of energy expenditure through p38 MAP kinase activation of PPAR coactivator-1. Mol. Cell 2001, 8:971-982.
29. Qiao L., MacDougald O.A., Shao J. CCAAT/enhancer-binding protein alpha mediates induction of hepatic phosphoenolpyruvate carboxykinase by p38 mitogen-activated protein kinase. J. Biol. Chem. 2006, 281:24390-24397.
30. Schoneveld O.J.L.M., Gaemers I.C., Lamers W.H. Mechanisms of glucocorticoid signaling. Biochim. Biophys. Acta 2004, 1680:114-128.
31. Schwartz M.W., Porte D. Diabetes, obesity, and the brain. Science 2005, 307:375-379.
32. Sun X., Yao H., Douglas R.M., Gu X.Q., Wang J., Haddad G.G. Insulin/PI3K signaling protects dentate neurons from oxygen-glucose deprivation in organotypic slice cultures. J. Neurochem. 2010, 112:377-388.
33. Van den Berghe G., Wilmer A., Milants I., Wouters P.J., Bouckaert B., Bruyninckx F., Bouillon R., Schetz M. Intensive insulin therapy in mixed medical/surgical intensive care units: benefit versus harm. Diabetes 2006, 55:3151-3159.
34. Wang Y.Y., Lin S.Y., Chuang Y.H., Chen C.J., Tung K.C., Sheu W.H.H. Adipose proinflammatory cytokine expression through sympathetic system is associated with hyperglycemia and insulin resistance in a rat ischemic stroke model. Am. J. Physiol. Endocrinol. Metab. 2011, 300:E155-E163.
35. Yamauchi T., Kamon J., Minokoshi Y., Ito Y., Waki H., Uchida S., Yamashita S., Noda M., Kita S., Ueki K., Eto K., Akanuma Y., Froguel P., Foufelle F., Ferre P., Carling D., Kimura S., Nagai R., Kahn B.B., Kadowaki T. Adiponectin stimulates glucose utilization and fatty acid oxidation by activating AMP-activated protein kinase. Nat. Med. 2002, 8:1288-1295.
36. Zhao H., Sapolsky R.M., Steinberg G.K. Phosphoinositide-3-kinase/akt survival signal pathways are implicated in neuronal survival after stroke. Mol. Neurobiol. 2006, 34:249-270.
37. Zhu C.Z., Auer R.N. Optimal blood glucose levels while using insulin to minimize the size of infarction in focal cerebral ischemia. J. Neurosurg. 2004, 101:664-668.